Transcode Therapeutics Inc
NASDAQ:RNAZ
Balance Sheet
Balance Sheet Decomposition
Transcode Therapeutics Inc
Current Assets | 4.5m |
Cash & Short-Term Investments | 2.8m |
Other Current Assets | 1.7m |
Non-Current Assets | 714.3k |
PP&E | 602.4k |
Other Non-Current Assets | 111.9k |
Current Liabilities | 3.5m |
Accounts Payable | 2m |
Accrued Liabilities | 1.5m |
Other Current Liabilities | 27.1k |
Non-Current Liabilities | 38.3k |
Other Non-Current Liabilities | 38.3k |
Balance Sheet
Transcode Therapeutics Inc
Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|
Assets | |||||||
Cash & Cash Equivalents |
0
|
0
|
1
|
21
|
5
|
3
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash Equivalents |
0
|
0
|
1
|
21
|
5
|
3
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Assets |
0
|
0
|
0
|
2
|
2
|
2
|
|
Total Current Assets |
0
|
0
|
1
|
23
|
7
|
4
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
0
N/A
|
0
-5%
|
1
+430%
|
23
+2 064%
|
8
-67%
|
5
-32%
|
|
Liabilities | |||||||
Accounts Payable |
0
|
0
|
0
|
3
|
3
|
2
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
2
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
0
|
0
|
0
|
3
|
4
|
3
|
|
Long-Term Debt |
0
|
1
|
2
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
2
|
0
|
0
|
0
|
|
Total Liabilities |
1
N/A
|
1
+82%
|
4
+240%
|
3
-43%
|
4
+72%
|
4
-19%
|
|
Equity | |||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
1
|
1
|
3
|
10
|
28
|
46
|
|
Additional Paid In Capital |
0
|
0
|
0
|
31
|
31
|
48
|
|
Total Equity |
1
N/A
|
1
-122%
|
3
-207%
|
20
N/A
|
3
-84%
|
2
-49%
|
|
Total Liabilities & Equity |
0
N/A
|
0
-5%
|
1
+430%
|
23
+2 064%
|
8
-67%
|
5
-32%
|
|
Shares Outstanding | |||||||
Common Shares Outstanding |
0
|
0
|
0
|
1
|
1
|
1
|